Content is user-generated and unverified.

Neuropathic Pain Medications in Palliative Care

NNT (Number Needed to Treat) and NNH (Number Needed to Harm) Comparison

Medication ClassSpecific DrugNNTNNHNNT/NNH RatioClinical Notes
Tricyclic Antidepressants (TCAs)Amitriptyline, Nortriptyline2.1-3.113.40.16-0.23Most effective - Lowest NNT, good safety profile
AnticonvulsantsCarbamazepine1.72.60.65Very effective but highest harm ratio
AnticonvulsantsGabapentin6-825.60.23-0.31Good safety profile, moderate efficacy
AnticonvulsantsPregabalin5-613.90.36-0.43Balanced efficacy and safety
SNRIsVenlafaxine~311.80.25Good efficacy, moderate safety
OpioidsVarious2.1-5.117.10.12-0.30Variable efficacy, good safety profile
TopicalCapsaicinNot available8.7-Limited systemic effects

Key Clinical Insights

Efficacy Ranking (Best to Worst NNT):

  1. Carbamazepine (NNT: 1.7) - Most effective
  2. Tricyclic Antidepressants (NNT: 2.1-3.1)
  3. Opioids (NNT: 2.1-5.1)
  4. SNRIs (NNT: ~3)
  5. Pregabalin (NNT: 5-6)
  6. Gabapentin (NNT: 6-8)

Safety Ranking (Best to Worst NNH):

  1. Gabapentin (NNH: 25.6) - Safest
  2. Opioids (NNH: 17.1)
  3. Tricyclic Antidepressants (NNH: 13.4)
  4. Pregabalin (NNH: 13.9)
  5. SNRIs (NNH: 11.8)
  6. Capsaicin (NNH: 8.7)
  7. Carbamazepine (NNH: 2.6) - Highest harm rate

Best Risk-Benefit Profile (Lowest NNT/NNH Ratio):

  1. Tricyclic Antidepressants (0.16-0.23) - BEST OVERALL
  2. Gabapentin (0.23-0.31)
  3. SNRIs (0.25)
  4. Opioids (0.12-0.30)
  5. Pregabalin (0.36-0.43)
  6. Carbamazepine (0.65) - High efficacy but concerning safety

Clinical Recommendations

First-line options:

  • Tricyclic Antidepressants: Best overall risk-benefit ratio
  • Gabapentin: Safest option with reasonable efficacy

Second-line options:

  • Pregabalin: Good balance of efficacy and safety
  • SNRIs: Moderate efficacy and safety

Special considerations:

  • Carbamazepine: Reserve for specific indications (trigeminal neuralgia) due to high NNH
  • Opioids: Consider for severe pain when other options fail
  • Capsaicin: Topical option for localized neuropathic pain

Important Note: Only 10-25% more patients achieve meaningful pain relief (≥50% reduction) compared to placebo across all medications.

Content is user-generated and unverified.
    Neuropathic Pain Medications: NNT and NNH Comparison Table | Claude